Showing results (41-50 of 342) with videos related to
Sort By:
Pageof 35
Ugeskrift for Laeger|January 16, 2007
[Cluster headache (Horton's headache)]Peer Tfelt-Hansen, Rigmor Højland JensenCephalalgia : an International Journal of Headache|September 9, 2020
Onset of action in placebo-controlled migraine attacks trials: A literature review and recommendationPeer Tfelt-Hansen, Hans-Christoph DienerCNS Drugs|October 12, 2007
Over-the-counter triptans for migraine : what are the implications?Peer Tfelt-Hansen, Timothy J SteinerCentral Nervous System Agents in Medicinal Chemistry|September 1, 2012
Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the futureDimos D Mitsikostas, Peer Tfelt-HansenHeadache|April 5, 2016
The Evidence for Prescription Information for Possible Use of a Repeated Dose of Oral Triptans: A CommentPeer Tfelt-Hansen, Stine F JespersenHeadache|January 8, 2009
Verapamil for cluster headache. Clinical pharmacology and possible mode of actionPeer Tfelt-Hansen, Jacob Tfelt-HansenCephalalgia : an International Journal of Headache|July 15, 2020
Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacksPeer Tfelt-Hansen, Hans-Christoph DienerPharmacology Research & Perspectives|July 15, 2015
The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1Lasse Saaby, Peer Tfelt-Hansen, Birger BrodinThe Journal of Headache and Pain|May 15, 2007
Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of ratPeer Tfelt-Hansen, Elisabeth Nilsson, Lars EdvinssonCephalalgia : an International Journal of Headache|August 19, 2021
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacksPeer Tfelt-Hansen, Karsten Jørgensen, Hans-Christoph DienerPageof 35